Form 13-F position report

KEZAR LIFE SCIENCES INC

Reported by Prosight Management LP

KZR CUSIP 49372L100 Manager CIK 0001617201

Reported 963,598 shares, down 2,401,735 (71.4%) from the prior quarter.

Reported value -72.8%; share count -71.4% vs. the prior quarter.

Reduced
% of reported 13F value 0.24% This manager · Q1 2024
Shares 963,598 Quarter-end amount reported
Reported value $868,780 Fair value at quarter end
Consecutive quarters held 20 Through Q1 2024

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-09-30 5443000
2021-12-31 6019000
2022-03-31 4986000
2022-06-30 10442000
2022-09-30 11433000
2022-12-31 12351180
2023-03-31 10016000
2023-06-30 11397204
2023-09-30 5677251
2023-12-31 3188316
2024-03-31 868780
2024-06-30 33648
2024-09-30 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

13 quarters
Quarterly reported position history for KEZAR LIFE SCIENCES INC held by Prosight Management LP.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2024 Reduced 0 -56,080 (-100.0%) 0 $0 2024-11-14
Q2 2024 Reduced 56,080 -907,518 (-94.2%) 0.01% $33,648 2024-08-14
Q1 2024 Reduced 963,598 -2,401,735 (-71.4%) 0.24% $868,780 2024-05-15
Q4 2023 Reduced 3,365,333 -1,405,466 (-29.5%) 1.28% $3,188,316 2024-02-14
Q3 2023 Added 4,770,799 +118,879 (2.6%) 1.8% $5,677,251 2023-11-14
Q2 2023 Added 4,651,920 +1,451,920 (45.4%) 3.34% $11,397,204 2023-08-14
Q1 2023 Added 3,200,000 +1,445,571 (82.4%) 4.75% $10,016,000 2023-05-12
Q4 2022 Added 1,754,429 +426,530 (32.1%) 6.74% $12,351,180 2023-02-14
Q3 2022 Added 1,327,899 +65,208 (5.2%) 6.13% $11,433,000 2022-11-14
Q2 2022 Added 1,262,691 +962,691 (320.9%) 8.23% $10,442,000 2022-08-12
Q1 2022 Reduced 300,000 -60,000 (-16.7%) 3.22% $4,986,000 2022-05-16
Q4 2021 Reduced 360,000 -269,957 (-42.9%) 3.6% $6,019,000 2022-02-14
Q3 2021 Reduced 629,957 -393,747 (-38.5%) 2.99% $5,443,000 2021-11-12
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

96 managers reported KEZAR LIFE SCIENCES INC for Q1 2024.

Managers reporting KEZAR LIFE SCIENCES INC in Q1 2024.
Manager Activity Shares Change % of reported 13F Reported value Tenure
SUVRETTA CAPITAL MANAGEMENT LLC Unchanged 7,167,591 0 0.24% $6,462,300 17 qtrs
Avidity Partners Management LP Added 5,026,000 +546 0.15% $4,531,442 13 qtrs
BlackRock Inc Reduced 4,616,988 -200,278 < 0.01% $4,162,677 24 qtrs
VANGUARD GROUP INC Added 3,094,224 +30,740 < 0.01% $2,789,753 24 qtrs
SPHERA FUNDS MANAGEMENT LTD Unchanged 2,051,676 0 0.26% $1,849,791 10 qtrs
ORBIMED ADVISORS LLC Unchanged 1,927,000 0 0.03% $1,737,383 8 qtrs
ACADIAN ASSET MANAGEMENT LLC Added 1,790,838 +534,203 < 0.01% $1,613,000 5 qtrs
Affinity Asset Advisors LLC New 1,761,778 +1,761,778 0.2% $1,588,419 1 qtr
GEODE CAPITAL MANAGEMENT LLC Added 1,373,689 +19,041 < 0.01% $1,238,643 23 qtrs
RENAISSANCE TECHNOLOGIES LLC Added 1,338,074 +46,155 < 0.01% $1,206,000 19 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
March 31, 2024
Filed
May 15, 2024
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
963,598
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.